Sales decline 13.35% to Rs 620.11 crore
Net Loss of Jubilant Life Sciences reported to Rs 7.47 crore in the quarter ended March 2016 as against net loss of Rs 206.89 crore during the previous quarter ended March 2015. Sales declined 13.35% to Rs 620.11 crore in the quarter ended March 2016 as against Rs 715.63 crore during the previous quarter ended March 2015.For the full year,net profit declined 61.45% to Rs 79.07 crore in the year ended March 2016 as against Rs 205.11 crore during the previous year ended March 2015. Sales declined 16.97% to Rs 2607.52 crore in the year ended March 2016 as against Rs 3140.62 crore during the previous year ended March 2015.
ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales620.11715.63 -13 2607.523140.62 -17 OPM %13.586.56 -13.078.79 - PBDT41.6022.30 87 200.20155.49 29 PBT19.89-0.38 LP 113.3448.08 136 NP-7.47-206.89 96 79.07205.11 -61
Powered by Capital Market - Live News
